| 摘要 |
The invention relates to medicine, particularly oncology and may be used to determine the spread of intestinal type gastric cancer.According to the invention the method consists in that after determining the type of gastric cancer is performed the serologic testing and are determined the markers CA 19-9, CA 125, the carcinoembryonal antigen, the human chorionic gonadotropin, the cytotoxic T-lymphocytes CD3 and T-helpers CD4, where the marker CA 19-9 is 50.0…200.0 IU/ml, CA 125 - 35.0…500.0 IU/ml, the carcinoembryonic antigen - 7.0…15.0 ng/ml, the human chorionic gonadotropin - 18…287 ng/ml, the cytotoxic T-lymphocytes CD3 - 28…54%, and the T-helpers CD4 - 10…20%, is determined the spread of intestinal type gastric cancer. |
